IBDEI04D ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5454,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,5454,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,5455,0)
 ;;=583.81^^40^408^5
 ;;^UTILITY(U,$J,358.3,5455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5455,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,5455,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,5455,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,5456,0)
 ;;=583.81^^40^408^16
 ;;^UTILITY(U,$J,358.3,5456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5456,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,5456,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,5456,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,5457,0)
 ;;=583.9^^40^408^6
 ;;^UTILITY(U,$J,358.3,5457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5457,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,5457,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,5457,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,5458,0)
 ;;=710.0^^40^408^17
 ;;^UTILITY(U,$J,358.3,5458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5458,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,5458,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,5458,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,5459,0)
 ;;=582.89^^40^409^2
 ;;^UTILITY(U,$J,358.3,5459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5459,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,5459,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,5459,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,5460,0)
 ;;=580.89^^40^409^1
 ;;^UTILITY(U,$J,358.3,5460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5460,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,5460,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,5460,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,5461,0)
 ;;=583.89^^40^409^3
 ;;^UTILITY(U,$J,358.3,5461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5461,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,5461,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,5461,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,5462,0)
 ;;=042.^^40^410^1
 ;;^UTILITY(U,$J,358.3,5462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5462,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,5462,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,5462,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,5463,0)
 ;;=581.1^^40^410^2
 ;;^UTILITY(U,$J,358.3,5463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5463,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,5463,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
 ;;^UTILITY(U,$J,358.3,5463,2)
 ;;=^270344
 ;;^UTILITY(U,$J,358.3,5464,0)
 ;;=581.2^^40^410^3
 ;;^UTILITY(U,$J,358.3,5464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5464,1,3,0)
 ;;=3^581.2
 ;;^UTILITY(U,$J,358.3,5464,1,4,0)
 ;;=4^NEPHROSIS MEMBRANOPROL
 ;;^UTILITY(U,$J,358.3,5464,2)
 ;;=^270345
 ;;^UTILITY(U,$J,358.3,5465,0)
 ;;=581.3^^40^410^4
 ;;^UTILITY(U,$J,358.3,5465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5465,1,3,0)
 ;;=3^581.3
 ;;^UTILITY(U,$J,358.3,5465,1,4,0)
 ;;=4^NEPHROSIS,MINIMAL CHANGE
 ;;^UTILITY(U,$J,358.3,5465,2)
 ;;=^82320
 ;;^UTILITY(U,$J,358.3,5466,0)
 ;;=581.9^^40^410^5
 ;;^UTILITY(U,$J,358.3,5466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5466,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,5466,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,5466,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,5467,0)
 ;;=446.0^^40^410^6
 ;;^UTILITY(U,$J,358.3,5467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5467,1,3,0)
 ;;=3^446.0
 ;;^UTILITY(U,$J,358.3,5467,1,4,0)
 ;;=4^POLYARTERITIS
 ;;^UTILITY(U,$J,358.3,5467,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,5468,0)
 ;;=581.81^^40^410^7
 ;;^UTILITY(U,$J,358.3,5468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5468,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,5468,1,4,0)
 ;;=4^SECONDARY NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,5468,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,5469,0)
 ;;=710.0^^40^410^8
 ;;^UTILITY(U,$J,358.3,5469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5469,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,5469,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,5469,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,5470,0)
 ;;=596.0^^40^411^1
 ;;^UTILITY(U,$J,358.3,5470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5470,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,5470,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,5470,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,5471,0)
 ;;=592.0^^40^411^2
 ;;^UTILITY(U,$J,358.3,5471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5471,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,5471,1,4,0)
 ;;=4^CALCULUS OF KIDNEY
 ;;^UTILITY(U,$J,358.3,5471,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,5472,0)
 ;;=592.1^^40^411^3
 ;;^UTILITY(U,$J,358.3,5472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5472,1,3,0)
 ;;=3^592.1
 ;;^UTILITY(U,$J,358.3,5472,1,4,0)
 ;;=4^CALCULUS OF URETER
 ;;^UTILITY(U,$J,358.3,5472,2)
 ;;=^124125
 ;;^UTILITY(U,$J,358.3,5473,0)
 ;;=591.^^40^411^4
 ;;^UTILITY(U,$J,358.3,5473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5473,1,3,0)
 ;;=3^591.
 ;;^UTILITY(U,$J,358.3,5473,1,4,0)
 ;;=4^HYDRONEPHROSIS
 ;;^UTILITY(U,$J,358.3,5473,2)
 ;;=^59672
 ;;^UTILITY(U,$J,358.3,5474,0)
 ;;=344.61^^40^411^5
 ;;^UTILITY(U,$J,358.3,5474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5474,1,3,0)
 ;;=3^344.61
 ;;^UTILITY(U,$J,358.3,5474,1,4,0)
 ;;=4^NEUROGENIC BLADDER
 ;;^UTILITY(U,$J,358.3,5474,2)
 ;;=^20561
 ;;^UTILITY(U,$J,358.3,5475,0)
 ;;=753.20^^40^411^6
 ;;^UTILITY(U,$J,358.3,5475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5475,1,3,0)
 ;;=3^753.20
 ;;^UTILITY(U,$J,358.3,5475,1,4,0)
 ;;=4^UNSP OBS DEF/RENAL PEL&URET
 ;;^UTILITY(U,$J,358.3,5475,2)
 ;;=^272985
 ;;^UTILITY(U,$J,358.3,5476,0)
 ;;=599.60^^40^411^8
 ;;^UTILITY(U,$J,358.3,5476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5476,1,3,0)
 ;;=3^599.60
 ;;^UTILITY(U,$J,358.3,5476,1,4,0)
 ;;=4^URINARY OBSTRUCTION NOS
 ;;^UTILITY(U,$J,358.3,5476,2)
 ;;=^332849
 ;;^UTILITY(U,$J,358.3,5477,0)
 ;;=599.69^^40^411^7
 ;;^UTILITY(U,$J,358.3,5477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5477,1,3,0)
 ;;=3^599.69
 ;;^UTILITY(U,$J,358.3,5477,1,4,0)
 ;;=4^URINARY OBSTRUCTION NEC
 ;;^UTILITY(U,$J,358.3,5477,2)
 ;;=^332813
 ;;^UTILITY(U,$J,358.3,5478,0)
 ;;=150.9^^40^412^6
 ;;^UTILITY(U,$J,358.3,5478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5478,1,3,0)
 ;;=3^150.9
 ;;^UTILITY(U,$J,358.3,5478,1,4,0)
 ;;=4^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,5478,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,5479,0)
 ;;=154.0^^40^412^5
 ;;^UTILITY(U,$J,358.3,5479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5479,1,3,0)
 ;;=3^154.0
 ;;^UTILITY(U,$J,358.3,5479,1,4,0)
 ;;=4^COLON CANCER
 ;;^UTILITY(U,$J,358.3,5479,2)
 ;;=^267089
 ;;^UTILITY(U,$J,358.3,5480,0)
 ;;=155.0^^40^412^10
 ;;^UTILITY(U,$J,358.3,5480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5480,1,3,0)
 ;;=3^155.0
 ;;^UTILITY(U,$J,358.3,5480,1,4,0)
 ;;=4^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,5480,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,5481,0)
 ;;=157.9^^40^412^17
 ;;^UTILITY(U,$J,358.3,5481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5481,1,3,0)
 ;;=3^157.9
 ;;^UTILITY(U,$J,358.3,5481,1,4,0)
 ;;=4^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,5481,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,5482,0)
 ;;=162.9^^40^412^11
 ;;^UTILITY(U,$J,358.3,5482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5482,1,3,0)
 ;;=3^162.9
 ;;^UTILITY(U,$J,358.3,5482,1,4,0)
 ;;=4^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,5482,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,5483,0)
 ;;=170.9^^40^412^2
 ;;^UTILITY(U,$J,358.3,5483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5483,1,3,0)
 ;;=3^170.9
 ;;^UTILITY(U,$J,358.3,5483,1,4,0)
 ;;=4^BONE CANCER
 ;;^UTILITY(U,$J,358.3,5483,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,5484,0)
 ;;=172.9^^40^412^14
 ;;^UTILITY(U,$J,358.3,5484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5484,1,3,0)
 ;;=3^172.9
 ;;^UTILITY(U,$J,358.3,5484,1,4,0)
 ;;=4^MELANOMA
 ;;^UTILITY(U,$J,358.3,5484,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,5485,0)
 ;;=173.81^^40^412^1
 ;;^UTILITY(U,$J,358.3,5485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5485,1,3,0)
 ;;=3^173.81
 ;;^UTILITY(U,$J,358.3,5485,1,4,0)
 ;;=4^BCCA SKIN,SITE NEC
 ;;^UTILITY(U,$J,358.3,5485,2)
 ;;=^340488
 ;;^UTILITY(U,$J,358.3,5486,0)
 ;;=173.82^^40^412^19
 ;;^UTILITY(U,$J,358.3,5486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5486,1,3,0)
 ;;=3^173.82
 ;;^UTILITY(U,$J,358.3,5486,1,4,0)
 ;;=4^SCCA SKIN,SITE NEC
 ;;^UTILITY(U,$J,358.3,5486,2)
 ;;=^340489
 ;;^UTILITY(U,$J,358.3,5487,0)
 ;;=173.89^^40^412^20
 ;;^UTILITY(U,$J,358.3,5487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5487,1,3,0)
 ;;=3^173.89
 ;;^UTILITY(U,$J,358.3,5487,1,4,0)
 ;;=4^SKIN CANCER-OTHER,SITE NEC
 ;;^UTILITY(U,$J,358.3,5487,2)
 ;;=^340490
 ;;^UTILITY(U,$J,358.3,5488,0)
 ;;=174.9^^40^412^3
 ;;^UTILITY(U,$J,358.3,5488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5488,1,3,0)
 ;;=3^174.9
 ;;^UTILITY(U,$J,358.3,5488,1,4,0)
 ;;=4^BREAST CANCER
 ;;^UTILITY(U,$J,358.3,5488,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,5489,0)
 ;;=180.9^^40^412^4
 ;;^UTILITY(U,$J,358.3,5489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5489,1,3,0)
 ;;=3^180.9
 ;;^UTILITY(U,$J,358.3,5489,1,4,0)
 ;;=4^CERVICAL CANCER
 ;;^UTILITY(U,$J,358.3,5489,2)
 ;;=^267214
 ;;^UTILITY(U,$J,358.3,5490,0)
 ;;=183.0^^40^412^16
 ;;^UTILITY(U,$J,358.3,5490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5490,1,3,0)
 ;;=3^183.0
 ;;^UTILITY(U,$J,358.3,5490,1,4,0)
 ;;=4^OVARIAN CANCER
 ;;^UTILITY(U,$J,358.3,5490,2)
 ;;=^267224
 ;;^UTILITY(U,$J,358.3,5491,0)
 ;;=185.^^40^412^18
 ;;^UTILITY(U,$J,358.3,5491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5491,1,3,0)
 ;;=3^185.
 ;;^UTILITY(U,$J,358.3,5491,1,4,0)
 ;;=4^PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,5491,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,5492,0)
 ;;=187.9^^40^412^13
 ;;^UTILITY(U,$J,358.3,5492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5492,1,3,0)
 ;;=3^187.9
 ;;^UTILITY(U,$J,358.3,5492,1,4,0)
 ;;=4^MALE GENITAL CANCER
 ;;^UTILITY(U,$J,358.3,5492,2)
 ;;=^267252
 ;;^UTILITY(U,$J,358.3,5493,0)
 ;;=193.^^40^412^21
 ;;^UTILITY(U,$J,358.3,5493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5493,1,3,0)
 ;;=3^193.
